Q
Qvella Corporation
Molecular diagnostics company with the goal of dramatically reducing time to results in bacteriology
About Qvella Corporation
Qvella Corporation is a biotechnology company focused on the rapid detection of bloodstream infections (BSI) to improve patient outcomes, particularly in cases of sepsis. The company operates in the healthcare diagnostics market, serving hospitals, clinical laboratories, and healthcare providers who require quick and accurate pathogen identification to administer timely and appropriate antimicrobial therapy. Qvella's core product, the FAST ID™ BSI Panel, is designed to identify over 90% of pathogens causing BSI within minutes, significantly faster than traditional methods that take hours or days. This rapid detection capability is crucial as every hour of delay in appropriate antibiotic therapy increases mortality rates associated with severe sepsis. Although the FAST ID™ BSI Panel is still under development and not yet approved for sale, Qvella's innovative approach has garnered significant interest and investment, including Series B financing and HTX funding. The company's business model revolves around the development and eventual commercialization of its diagnostic technologies, generating revenue through product sales and potentially through partnerships and licensing agreements.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| FundingOther financing | Sep 2021 | $0 | — | Hatteras Venture Partners · Sands Capital Management · Whitecap Venture Partners · RA Capital Management | — |
| FundingOther financing | Aug 2020 | $0 | — | Hatteras Venture Partners · Whitecap Venture Partners · RA Capital Management · Sands Capital Management | — |
Growth signals
Latest recorded traffic for Qvella Corporation is 490 monthly website visits, down 62.3% over the last three months. Qvella Corporation's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Qvella Corporation in the Richmond Hill ecosystem
The Qvella Corporation office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
RA Capital Management
Whitecap Venture Partners
Hatteras Venture Partners
Other known investors3 additional known investors
Sands Capital Management
David Geffen School of Medicine at UCLA
University of California, Los Angeles
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Qvella Corporation on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Qvella Corporation’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









